Radiotherapy-induced nausea, vomiting associated with worsening quality of life
the ONA take:
Patients’ subjective experiences of radiotherapy-induced nausea and vomiting (RINV) correlated to the worsening of quality of life outcomes, according to a new study published online ahead of print in the journal Supportive Care in Cancer.
For the study, researchers enrolled 58 patients with gastrointestinal cancer undergoing treatment with abdominal radiotherapy alone or with concomitant chemoradiotherapy.
The investigators recorded all episodes of nausea, vomiting, and antiemetic use daily for the treatment period and the week following completion of treatment.
Results showed that in total, 351 episodes of nausea severity, duration, onset time, and 154 outcomes of vomiting onset times and contents were recorded. The most common durations of nausea were 30 minutes or less and consistent nausea all day and night.
Researchers found that longer nausea duration, greater nausea severities, the location of nausea experienced, and the onset timing and number of vomiting episodes significantly negatively impacted quality of life.
The findings suggest that the identification and amelioration of these RINV experiences could improve quality of life in patients with gastrointestinal cancer receiving radiotherapy.
Patients’ subjective experiences of radiotherapy-induced nausea and vomiting (RINV) correlated to the worsening of quality of life outcomes.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Earlier and Later Adult BMI Associated With Multiple Myeloma Risk
- Cost-Effectiveness of Immunotherapy for Advanced Melanoma Evaluated
- VBPWPs Can Compliment Patient Management in Clinical Trials
- Communication Technology Improves Treatment Burden, Patient Perspective of Oncology Care
- Pediatric Patients, Parents Overreport Adherence to ALL Medication Regimen
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|